CClinicalTrials.gg
RecruitingNCT06249880Updated Mar 9, 2026

Pediatric Normative Markerless Movement Analysis

An observational study in Pediatric ALL and Adolescent, sponsored by MultiCare Health System Research Institute. Recruiting at 1 site in United States. Open to participants aged 3 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-09.

Sponsored by MultiCare Health System Research Institute · Observational

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 7 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
40
Ages
3 Years to 25 Years
Sex
All
01

Study summary

The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.

Read the detailed description

The objective of this project is to collect baseline data from a normative population of children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab. This project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.

02

Conditions studied

  • Pediatric ALL
  • Adolescent

Keywords

  • Motion Analysis
  • Kinetics
  • Kinematics
03

In context

Precursor Cell Lymphoblastic Leukemia-Lymphoma

2,061 studies on the registry are indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma; 490 are open to participants now.

This study's planned enrollment of 40 is below the median of 120 across 300 observational studies indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma.

Browse Precursor Cell Lymphoblastic Leukemia-Lymphoma studies →

Lead sponsor

MultiCare Health System Research Institute is the lead sponsor of 14 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects will be recruited from the regional community, including convenience sample of children. Subjects will be recruited by word of mouth, posted flyers, and advertised through the RML website and MB social media.

Inclusion criteria

  • Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion).
  • Ambulate independently and without the use of assistive devices or orthoses.
  • Willing and interested in participating.

Exclusion criteria

Exclusion Criteria:

  • Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues.
  • Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity.
  • Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment.
  • History of premature birth.
  • Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Normative

    40 neurotypical pediatric subjects

    Other: Observation

Interventions

  • OtherObservation

    This project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.

06

What researchers measure

Primary outcomes

  1. Observation-based movement analyses

    The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Mary Bridge Children's Therapy Unit - Research & Movement Lab
    Puyallup, Washington 98372, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06249880
Lead sponsor
MultiCare Health System Research Institute
Responsible party
Brenna Brandsma (Physical Therapist, MultiCare Health System Research Institute) — Principal investigator
First posted
Feb 8, 2024
Start date
Mar 1, 2024
Primary completion
Dec 2027 (estimated)
Completion
Dec 2028 (estimated)
Last update
Mar 9, 2026

Study contacts

Brenna Brandsma, PT, DPT, PCS
Contact
brenna.brandsma@multicare.org
253-697-5268
Sean Brown, PhD
Contact
sean.brown@multicare.org
253-697-5402
Brenna Brandsma
principal investigator · Mary Bridge Chidlren's

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion